Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation

Conditions:   Percutaneous Coronary Intervention (PCI);   Atrial Fibrillation (AF);   Oral Anticoagulation;   P2Y12 Inhibitor Interventions:   Drug: P2Y12 inhibitors (clopidogrel, ticagrelor, prasugrel);   Drug: Aspirin;   Drug: DOAC Sponsors:   Insel Gruppe AG, University Hospital Bern;   Sahajanand Medical Technologies Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials